Feature

NHS launches world’s largest AI trial for breast cancer diagnosis

Love it or hate it, there’s no denying that artificial intelligence has had a monumental effect on industry, society, and humanity as a whole.

04/03/2025 10:41:14

Font size:

Whilst the technology’s rise – especially that of generative AI – continues to spark serious environmental and existential concerns, it’s equally true that artificial intelligence can also have a hugely positive impact when used conscientiously.

Nowhere is this truer than in the medical industry. AI has huge potential not only in streamlining healthcare, but also in accelerating life-changing scientific research.

One exciting example that hit the press last month was the announcement that the NHS would be testing the effectiveness of artificial intelligence in detecting breast cancer earlier.

The £11m EDITH (Early Detection using Information Technology in Health) trial is part of the Government’s wider push to integrate more digital technologies into healthcare. It will see nearly 700,000 women across the country participate in what will be the world’s largest trial of its kind to date.

Read the full article in DPA's March 2025 issue

Written By Sophia Bell

Sophia Bell is the Group Editor of DPA, Connectivity, and PBSI. She joined the team in 2020 as Assistant Editor after achieving a First-Class Honours BA in English Literature and Film Studies from the University of East Anglia. In her current role, she leads the editorial strategy, driving digital growth and ensuring each title continues to deliver trusted, relevant insight for engineering and manufacturing professionals.